Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
S&P Biotech SPDR
(NY:
XBI
)
97.51
+0.87 (+0.90%)
Official Closing Price
Updated: 8:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about S&P Biotech SPDR
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Option Bears Reloading as Bulls Feeling Spry
June 22, 2022
As the bulls have their moment, the bears are adding bearish options positions and rolling up into the strength.
Via
Talk Markets
Stock Drop On June 16, But A Rally May Be Coming After Options Expiration
June 16, 2022
Another miserable day for stocks, with the S&P 500 dropping 3.25%
Via
Talk Markets
Do Crispr And Vertex Have A 'Functional Cure' For Blood Diseases?
June 13, 2022
Crispr and Vertex tested their gene-edited drug in two blood diseases.
Via
Investor's Business Daily
“Chip Shot” Stock Market (And Sentiment Results)
June 02, 2022
Chips are the key to the economy/inflation moving forward. They are also the key to one of our major new positions in an auto-supplier
Via
Talk Markets
3 Biotech Stocks to Buy Before They Boom
June 01, 2022
It could be a “never-before, never-after opportunity” to buy into these biotech stocks that trade at very attractive valuations.
Via
InvestorPlace
The “Shake It Off” Stock Market (And Sentiment Results)
April 07, 2022
We may be close to a short term peak in yields – bottom in bonds
Via
Talk Markets
Again, Buy ‘Em
May 31, 2022
Today we discuss again why it’s time to start adding back risk. We cover the major breadth thrusts that fired, some great monthly charts, and more.
Via
Talk Markets
As COVID Subsidies, Here are 8 Infectious Diseases That Could Emerge As Potent Threats
May 30, 2022
The COVID-19 pandemic that emerged in early 2020 doesn't seem to have run its course. Daily average cases, though have declined notably, stood at 110,084 in the U.S. as of Thursday, according to data...
Via
Benzinga
PreMarket Prep: Looking For Biotech Bargains With This Wedbush Analyst
May 25, 2022
Biotechnology is one sector that peaked ahead of the S&P 500 index. While the S&P 500 index did not peak until January, the SPDR Biotech (NYSE: XBI) peaked in February 2021 and is now 60% lower than...
Via
Benzinga
This Biotech Looks Good With Increased M&A activity
May 20, 2022
Fierce Biotech backs this up: “Biopharmas have $1.7 trillion to spend on deals this year, and big players like Novartis, Pfizer and Merck & Co. have made it pretty clear they’re on the hunt for...
Via
Talk Markets
The “Mystery Liquidator Revealed” Stock Market (And Sentiment Results)
May 19, 2022
In this week’s AAII Sentiment Survey result, Bullish Percent ticked up a hair to 26% this week from 24.3% last week. Bearish Percent rose to 50.4% from 49%.
Via
Talk Markets
Large Cap Biopharmaceuticals: Provide Growth, Value And Yield
May 16, 2022
Now that all major biopharmaceutical earnings are in, we can review the financial metrics and see if our portfolio needs re-balancing.
Via
Talk Markets
When Will The Stock Market Stop Falling?
May 12, 2022
Stocks have fallen dramatically just this past week, is a bottom near?
Via
Talk Markets
Stocks Tank On May 11 With No Bottom In Sight
May 11, 2022
Despite the sharp decline, the VIX finished down on the day at 32.5. It tells us there was “real” selling in the market today.
Via
Talk Markets
7 Biotech Stocks With Key Catalysts for May
May 11, 2022
The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns.
Via
InvestorPlace
Should Biotech Be On The Critical List?
May 11, 2022
The risk-off market has played havoc with the biotechs where the fundamentals have not changed as much as the valuation.
Via
Talk Markets
“Threading The Needle” Stock Market (And Sentiment Results)
May 05, 2022
Two weeks ago AAII sentiment survey dropped to a 30 year low at 15.8% bullish. Last week it ticked up modestly to 16.4%.
Via
Talk Markets
7 Monster Stock Market Predictions For The Week Of April 25
April 23, 2022
The week ending April 22 was brutal. The S&P 500 fell by nearly 2.75%, but things were much worse than that. Powell unleashed hell when he noted that a 50 bps rate hike was on the table for the FOMC...
Via
Talk Markets
The “magic Chart” Stock Market (And Sentiment Results)
April 21, 2022
We have now come to a point Where the market has priced in more rate hikes than are likely to occur.
Via
Talk Markets
4 Undervalued Biotech Stocks to Add to Your Buy List
April 20, 2022
These biotech stocks have seen their valuations tumble in the year-to-date sell-off. But they have the wherewithal to bounce big and generate decent, market-beating returns.
Via
InvestorPlace
Healthcare Stocks Lead the Way Up as the Market Fades
April 11, 2022
With inflation and energy costs soaring, the Fed ever threatening with higher rates and headlines from the war in Ukraine investors are seeking more defensive positions.
Via
Talk Markets
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
April 08, 2022
Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now.
Via
InvestorPlace
Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks
April 08, 2022
Cash will be king in biotech picks like BLUE stock as governments slow approvals and reimbursements of new gene therapies.
Via
InvestorPlace
Sunshine Biopharma Stock Triples on Positive mRNA Cancer Treatment Results
April 05, 2022
SBFM stock tripled to $6.53 on Tuesday after revealing that two of its newly designed mRNA molecules are effective in destroying cancer cells.
Via
InvestorPlace
Good Entry Point for Biotech Stocks
April 04, 2022
Life science and biotech stocks had a good week with the most well-known ETFs up 3-4% for the week and off recent bottoms.
Via
Talk Markets
CNBC's Final Call: Newmont, Biotech ETF And This Energy Stock
April 04, 2022
On CNBC's "The Final Call," Carter Worth recommended Newmont Corporation (NYSE: NEM). The stock has jumped almost 36% year to date.
Via
Benzinga
Acadia: Helping With Alzheimers And Parkinsons
April 03, 2022
Things always change fast in biotech, but until recently things have been moving consistently to the downside. It’s been a while, but we believe this is finally over. And we believe Acadia...
Via
Talk Markets
Biotech Funds and ETFs Continue to Lag
March 28, 2022
It’s no secret that market sectors driving inflation are leading the market. With the US economy still strong and the War in Ukraine limiting supply of nat gas and raw materials, producer costs are...
Via
Talk Markets
How do Biotechnology Funds and ETFs Perform Over Five Years?
March 21, 2022
Biotech investing can be difficult for short-term traders but can offer good returns over five years if balanced with other healthcare positions like the XLV.
Via
Talk Markets
AskSlim Market Week - Friday, March 18
March 18, 2022
Technical and cycle analysis, and market commentary.
Via
Talk Markets
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.